Kimberly J. Popovits has been a part of 10x Genomics, Inc. since March 2020, stepping in as a director and bringing her extensive experience to the board. She previously served as the President and CEO of Genomic Health, Inc., a...

Current Market Cap

$1.62B

Number of Employees

1.26K

Total Compensation

2020 - 2023

Trending down by -100.00% last year
Showing total compensation for the last 2020 - 2023

Stock

Up by 0.00% last year

Salary

Down by -100.00% last year

Bonus

Up by 0.00% last year

Other

Up by 0.00% last year

Year

2023

Total Compensation

$0.00

Salary

$0.00

Board Justification

The compensation philosophy emphasizes pay-for-performance and aligns executive compensation with company performance and market benchmarks.

Bonus

$0.00

Board Justification

No bonus was awarded to Kimberly J. Popovits in 2023.

Other

$0.00

Board Justification

No other compensation was reported for Kimberly J. Popovits in 2023.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock awards vested in 2023 for Kimberly J. Popovits.

Performance Metrics

Performance metrics for Kimberly J. Popovits' compensation were based on company performance, but specific metrics were not disclosed.

SEC Filing

From April 26, 2024

Kimberly J. Popovits

Ex-CEO of Talis Biomedical Corporation

1

Education

Field of Expertise

Healthcare & Life Sciences - Healthcare

Born

Invalid Date - 0 years ago

Is Founder?

No

Tenure

0 years 3 months (Aug 2021 - Dec 2021)

Previous Experience

Former Chair of the Board of Directors, President and Chief Executive Officer of Genomic Health.

View Holdings

Insider Holdings of Kimberly J. Popovits

KNSATXG

$601.22K

$24.24K (4.20%)

Last Insider Trade

TXG

8,649 shares

TXG

Jun 11, 2024

Received